Nu får de testa cancerläkemedel på barn

Barncancervården på Sahlgrenska har godkänts som kliniskt prövningscentrum för att utvärdera läkemedel på barn.

Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Tummen upp för Sobi

CHMP rekommenderar bolagets behandling mot blodsjukdomen hemofili A.

Fat cells' reaction differs with body weight

The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

An industry emerging from crisis

"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "

EMA granskar Alprolix

Inleder genomgång av Sobis marknadsansökan.

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

How to get the most out of the fair

Lovande från Sobi

Visar positiva resultat från en pediatrisk fas III-studie med sin behandling mot blödarsjukdomen hemofili b.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Positivt i Sobis barnstudie

Sobi och partnern Biogen redovisar positiva fas III-resultat i blödarsjukaprojektet A-long.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Presenterar data från två kliniska studier

Sobi och partnern Biogen visar upp nya resultat på kongress i Kanada.

Sundin ger miljoner till forskning

Finansierar tjänster i Solna och Toronto.

Ambassador program makes MVA big in Japan

The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...

Floppat diabetesvaccin visar positiv effekt

Nya forskningsresultat visar att Diamyd-vaccinets immunologiska effekt håller i sig fyra år efter behandling.

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...

Enjoy Stockholm - the capital of Scandinavia

Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...